✦ LIBER ✦

Safety and efficacy of peginterferon alpha-2b plus ribavirin in pre-cirrhotic and cirrhotic patients with chronic hepatitis C

✍ Scribed by Marrache, Frederic; Ripault, Marie Pierre; Consigny, Yann; Hatem, Dominique Cazals; Boyer, Nathalie; Martinot, Michele; Degott, Claude; Valla, Dominique; Marcellin, Patrick

Book ID: 122365716
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 249 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83886-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alpha-2b plus ribavirin vs

Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients

✍ M. Crespo; S. Sauleda; J. I. Esteban; A. Juarez; E. Ribera; A. L. Andreu; V. Fal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

Safety and efficacy of peginterferon alp

Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease

✍ Emanuele Durante-Mangoni; Domenico Iossa; Daniela Pinto; Lucia De Vincentiis; En 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Early virologic response after peginterf

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

✍ A. M. Di Bisceglie; R. H. Ghalib; F. M. Hamzeh; V. K. Rustgi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

P1234 SAFETY AND EFFICACY OF MK-5172 PLU

P1234 SAFETY AND EFFICACY OF MK-5172 PLUS PEGINTERFERON ALFA-2b AND RIBAVIRIN (PR) IN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G)1 INFECTION

✍ Hezode, C.; Bruno, S.; Jacobson, I.; Serfaty, L.; Kwo, P.; Zhou, A.; Gilbert, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy and safety of peginterferon alp

Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C

✍ Richard Njouom; Michèle Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract Data were examined from a day‐to‐day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa‐2a and ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Ninety adults with chronic hepatitis C (mean age, 53 ± 8 years; 79% ma

Safety and efficacy of peginterferon plu

Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis

✍ F. Marrache; Y. Consigny; M. P. Ripault; D. Cazals-Hatem; M. Martinot; N. Boyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB